Article: New, Low Dose Formulation of Nation's #1 Prescribed Birth Control Pill Approved by FDA; ORTHO TRI-CYCLEN(R) LO Is Highly Effective with a Favorable Side Effect Profile.

RARITAN, N.J. -- The U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive, ORTHO TRI-CYCLEN (R) LO (norgestimate/ethinyl estradiol) Tablets for the prevention of pregnancy. ORTHO TRI-CYCLEN LO will be available by prescription in the fall.

(Photo: http://www.newscom.com/cgi-bin/prnh/20020823/CGF017 )

Like other oral contraceptives, ORTHO TRI-CYCLEN LO, is highly effective when taken correctly. It contains a combination of hormones - 25 micrograms (mcg) of estrogen and the progestin, norgestimate - which provides excellent cycle control and tolerability.

ORTHO TRI-CYCLEN LO was developed by Ortho-McNeil Pharmaceutical, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!